We are attending #JADPROLive, the Advanced Practitioner Society For Hematology And Oncology (APSHO) Annual Meeting! Visit us at Booth #517 and learn about our mission to positively impact patient lives and defeat cancer. More about this event can be found here: https://jadprolive.com/ #BelieversInTheExtraordinary #BelieversInPatients
Karyopharm Therapeutics Inc.
Pharmaceutical Manufacturing
Newton, MA 32,831 followers
Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need.
About us
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
- Website
-
http://www.karyopharm.com
External link for Karyopharm Therapeutics Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Newton, MA
- Type
- Public Company
- Founded
- 2008
- Specialties
- oncology, pharmaceutical, biotech, multiplemyeloma, lymphoma, solidtumors, clinicalresearch, clinicaltrials, research, drugdiscovery, medical, and healthcare
Locations
-
Primary
Get directions
85 Wells Avenue
Newton, MA 02459, US
Employees at Karyopharm Therapeutics Inc.
Updates
-
Thank you to all who have served and those who continue to serve our country - you are extraordinary. #VeteransDay #BelieversInTheExtraordinary #BelieversInOurPeople
-
We reported third quarter 2024 financial results and recent company highlights earlier today. Learn more here: https://bit.ly/3Ys2BWA
-
Karyopharm reports third quarter 2024 financial results and highlights recent company progress. Tune in on Tuesday, November 5 at 8 a.m. EST. Learn more here: https://bit.ly/4fiZNCv
-
Proud to partner with MPN Research Foundation to help bridge the gaps between unmet needs and real solutions for patients! Together we are shaping the future of MPN care.
MPN Research Foundation (MPNRF) has built strong, trusted partnerships with patients, caregivers, researchers, and biopharma, giving us a unique advantage in bridging the gap between unmet needs and real solutions. One of many initiatives driving meaningful research forward is our MPN Patient & Caregiver Unmet Needs Survey. By gathering input directly from those impacted by MPNs, we can identify critical gaps in care and support, ensuring future research addresses the most pressing needs. Your insights are vital to shaping the future of MPN care. The survey closes on November 11th—don’t miss the chance to contribute to this important work. 👉 Take the survey today: [ https://lnkd.in/g7betXRY ] Give the gift of MPN research this holiday season: Together, we can accelerate real solutions in the evolving MPN landscape. Thank you to our sponsors for supporting this initiative. Bristol Myers Squibb Incyte Karyopharm Therapeutics Inc. PharmaEssentia MorphoSys Sobi - Swedish Orphan Biovitrum AB (publ) 住友ファーマ株式会社 (Sumitomo Pharma)
-
We are pleased to announce a favorable change in the co-primary endpoint for our Pivotal Phase 3 SENTRY trial in myelofibrosis. Watch the replay of our announcement as we discussed the importance of this update with Dr. Raajit Rampal and Dr. John Mascarenhas: https://bit.ly/4f83gE2 Read more about this update here: https://bit.ly/4fqq1CH #BelieversInTheExtraordinary #BelieversInPatients
-
-
Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024. Learn more: https://bit.ly/4f6bqMT
-
-
We are #BelieversInPatients and proud to be a sponsor at CR&T's 13th International Patient Symposium on Myeloproliferative Neoplasms (MPNs) today in NYC. We are excited to engage with distinguished MPN researchers and physicians as we continue our mission to positively impact patient lives and defeat cancer. Learn more about the event here: https://bit.ly/3YrKAsX #MPNSymposium2024 #CR&T #BelieversInTheExtraordinary
-
-
Last night we gathered at #LightTheNightBoston to celebrate, honor, and remember those affected by #bloodcancers. Learn more about this event and The Leukemia & Lymphoma Society's efforts here: https://bit.ly/3Xxl2IY #BelieversInTheExtraordinary #BelieversInPatients
-
-
We are excited to attend the Lymphoma, Leukemia & Myeloma Congress in New York City where we will share real-world use and survival research on an XPO1 inhibitor for patients with relapsed/refractory #multiplemyeloma. Learn more about the congress here: https://bit.ly/3XYygjm #LLMCongress2024 #BelieversInTheExtraordinary
-